Publications

Literature Focused on Informed Consent

  • J.A. Sauceda, K. Dubé, B. Brown, A.E. Pérez, C.E. Rivas, D. Evans, C.B. Fisher. Framing a Consent Form to Improve Knowledge and Determine How This Affects Willingness to Participate in HIV Cure-Research Research: An Experimental Survey Study. Journal of Empirical Research on Human Research Ethics 2020; Dec 14; 1556264620981205. PubMed: https://pubmed.ncbi.nlm.nih.gov/33307932/

Literature Focused on the Psychosocial Aspects of HIV Cure Research Participation

  • Dubé, K., Ndukwe, S. O., Korolkova, A., Dee, L., Sugarman, J., & Sauceda, J. A. (2024). Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States. HIV research & clinical practice, 25(1), 2312318. PubMed: https://pubmed.ncbi.nlm.nih.gov/38348830/
  • Bilger, A., Plenn, E., Barg, F. K., Rendle, K. A., Carter, W. B., Lamour-Harrington, A., Jones, N., Peterson, B., Sauceda, J. A., Tebas, P., Mounzer, K., Metzger, D., Montaner, L. J., & Dubé, K. (2023). Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States. HIV research & clinical practice, 24(1), 2267825. PubMed: https://pubmed.ncbi.nlm.nih.gov/37837376/
  • K. Dubé, L. Barr, D. Palm, B. Brown, J. Taylor. Putting Participants at the Centre of HIV Cure Research. Lancet HIV 2019; 6(3): e147 – 9. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30772419
  • K. Dubé, S. Eskaf, L. Barr, D. Palm, E. Hogg, J.M. Simoni, J. Sugarman, B. Brown, J.A. Sauceda, L. Henley, S. Deeks, L. Fox, R.T. Gandhi, D. Smith, J.Z. Li. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP): Results from the AIDS Clinical Trials Group (ACTG) 5345 Biomarker Study. AIDS Research and Human Retroviruses 2022; 38(6): 510-7. PubMed: https://pubmed.ncbi.nlm.nih.gov/35323030/
  • K.L. Diepstra, L. Barr, D. Palm, E. Hogg, K.R. Mollan, L. Henley, A.M. Stover, J.M. Simoni, J. Sugarman, B. Brown, J.A. Sauceda, S. Deeks, L. Fox, R.T. Gandhi, D. Smith, J.Z. Li, K. Dubé. Participant Perspectives Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trial Group A5345 Study. AIDS Research and Human Retroviruses 2021; 37(6): 489 – 501. PubMed: https://pubmed.ncbi.nlm.nih.gov/33472545/
  • K. Dubé, L. Hosey, K. Starr, L. Barr, D. Evans, E. Hoffman, D.M. Campbell, J. Simoni, J. Sugarman, J. Sauceda, B. Brown, K.L. Diepstra, C. Godfrey, D.R. Kuritzkes, D.A. Wohl, R. Gandhi, E. Scully. Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group (ACTG) 5366. AIDS Research and Human Retroviruses 2020; 36(4): 268 – 82. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32160755

Literature Pertinent to Delphi Consensus Building Challenges

  • K. Dubé, T. Morton, L. Fox, L. Dee, D. Palm, T. J. Villa, W. Freshwater, J. Taylor, G. Graham, W. B. Carter, J. A. Sauceda, M. J. Peluso, A. Rid. A Partner Protection Package for HIV CURE-Related Trials Involving Analytical Treatment Interruptions. The Lancet Infectious Diseases. (2023). PubMed: https://pubmed.ncbi.nlm.nih.gov/37295453/
  • K. Dubé, J. Kanazawa, C. Campbell, C. Boone, A.C. Maragh-Bass, D.M. Campbell, M. Agosto-Rosario, J.K. Stockman, T. Poteat, M.O. Johnson, P. Saberi, J.A. Sauceda. Considerations for Involving Women and Racial, Ethnic, Sexual and Gender Minorities in HIV Cure-Related Research with Analytical Treatment Interruption: A Qualitative Inquiry. AIDS Research and Human Retroviruses 2022; 38(1): 50 – 63. PubMed: https://pubmed.ncbi.nlm.nih.gov/33947268/
  • T. Poteat, A. Aqil, D. Corbett, D. Evans, K. Dubé. “I Would Really Want to Know That They Had My Back”: Transgender Women’s Perceptions of HIV Cure-Related Research in the United States. PLoS One 2020; 15(12): e0244490. PubMed: https://pubmed.ncbi.nlm.nih.gov/33382760/

Literature Pertinent to Partner Protections during ATIs

  • K. Dubé, J. Kanazawa, L. Dee, J. Taylor, D.M. Campbell, B. Brown, M.O. Johnson, P. Saberi, J.A. Sauceda, J. Sugarman, M.J. Peluso. Ethical and Practice Considerations for Mitigating Risks to Sexual Partners during Analytical Treatment Interruptions in HIV Cure-Related Research. HIV Research and Clinical Practice 2021 Mar 24: 1 – 17. PubMed: https://pubmed.ncbi.nlm.nih.gov/33757411/
  • M. J. Peluso, L. Dee, D. Campbell, J. Taylor, R. Hoh, R.L. Rutishauser, J. Sauceda, S. G. Deeks, K. Dubé. A Collaboratory, Multi-Disciplinary Approach to Risk Mitigation during HIV Analytical Treatment Interruption. Journal of Virus Eradication 2020; 6(1): 34 – 7. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32175090
  • K. Dubé, H. Agarwal, J.K. Stockman, J.D. Auerbach, J.A. Sauceda, A.A. Conroy, M.O. Johnson. “I would absolutely need to know that my partner is still going to be protected”: Perceptions of HIV Cure-Related Research among Diverse HIV Serodifferent Couples in the United States. AIDS Research and Human Retroviruses 2022 Aug. PubMed: https://pubmed.ncbi.nlm.nih.gov/35972752/
  • D.M. Campbell*, K. Dubé* (joint first authors), P.D. Cowlings, P. Dionicio, R.M. Tam, H. Agarwal, J.K. Stockman, D.J. Auerbach, J.A. Sauceda, A.A. Conroy, M.O. Johnson. “It comes altogether as one”: Perceptions of Analytical Treatment Interruptions and Partner Protections among Racial, Ethnic, Sex and Gender Diverse HIV Serodifferent Couples in the United States. BMC Public Health 2022 Jul 9; 22(1): 1317. PubMed: https://pubmed.ncbi.nlm.nih.gov/35810288/

Other Literature of Interest

  • K. Dubé, D. Mthimkhulu, W. Ngcobo, D. Mindry, L. Maphalala, V. Pillay, W. Tran, A. Korolkova, T. Ndung'u, K. Dong. 'With this Study, We Have Hope that Something is Coming': Community Members' Perceptions of HIV Cure-related Research in Durban, South Africa - A Qualitative Focus Group Study. (2023). PubMed: https://pubmed.ncbi.nlm.nih.gov/37555592/
  • K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. Applying the Functional Behavioral and Social Sciences Research (BSSR) Framework to HIV Cure Research. Journal of the International AIDS Society (JIAS) 2019;  22: e25404. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31665568.
  • B. Julg, L. Dee, J. Ananworanich, D. Barouch, K. Bar, M. Caskey, D. Colby, L. Dawson, K. Dong, K. Dubé, J. Eron, J. Frater, R. Gandhi, R. Geleziunas, P. Goulder, G. Hanna, R. Jefferys, R. Johnston, D. Kuritzkes, J. Li, U. Likhitwonnawut, J. van Lunzen, J. Martinez-Picado, V. Miller, L. Montaner, D. Nixon, D. Palm, G. Pantaleo, H. Peay, D. Persaud, J. Salzwedel, K. Salzwedel, T. Schacker, V. Sheikh, O. Søgaard, S. Spudich, K. Stephenson, J. Sugarman, J. Taylor, P. Tebas, C. Tiemessen, R. Tressler, C. Weiss, S. Zheng, M. Robb, N. Michael, J. Mellors, S. Deeks, B. Walker. Recommendations for Analytical Treatment Interruption in HIV Remission Trials – Report of a Consensus Workshop. Lancet HIV 2019; 6(4): e259 – 68. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30885693
  • K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown, D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J. Kanazawa, K. Perry, H. Patel, S. Luter, T. Poteat, J.D. Auerbach, D.A. Wohl. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Research and Human Retroviruses 2020; 36(4): 324 – 48. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31608651